DNLI
Price
$13.67
Change
-$0.64 (-4.47%)
Updated
Jul 25 closing price
Capitalization
1.99B
5 days until earnings call
ELVN
Price
$21.20
Change
-$0.75 (-3.42%)
Updated
Jul 25 closing price
Capitalization
1.25B
12 days until earnings call
Interact to see
Advertisement

DNLI vs ELVN

Header iconDNLI vs ELVN Comparison
Open Charts DNLI vs ELVNBanner chart's image
Denali Therapeutics
Price$13.67
Change-$0.64 (-4.47%)
Volume$1.18M
Capitalization1.99B
Enliven Therapeutics
Price$21.20
Change-$0.75 (-3.42%)
Volume$183.61K
Capitalization1.25B
DNLI vs ELVN Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. ELVN commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (DNLI: $13.67 vs. ELVN: $21.20)
Brand notoriety: DNLI and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 77% vs. ELVN: 34%
Market capitalization -- DNLI: $1.99B vs. ELVN: $1.25B
DNLI [@Biotechnology] is valued at $1.99B. ELVN’s [@Biotechnology] market capitalization is $1.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 5 bearish.
  • ELVN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -2.36% price change this week, while ELVN (@Biotechnology) price change was -6.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

DNLI is expected to report earnings on Oct 30, 2025.

ELVN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($1.99B) has a higher market cap than ELVN($1.25B). ELVN YTD gains are higher at: -5.778 vs. DNLI (-32.924). ELVN has higher annual earnings (EBITDA): -109.95M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. ELVN (290M). ELVN has less debt than DNLI: ELVN (365K) vs DNLI (48.6M). DNLI (0) and ELVN (0) have equivalent revenues.
DNLIELVNDNLI / ELVN
Capitalization1.99B1.25B159%
EBITDA-505.16M-109.95M459%
Gain YTD-32.924-5.778570%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M290M282%
Total Debt48.6M365K13,315%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIELVN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIADX57.53N/A
N/A
Fidelity Advisor International Discv I
LFEIX23.87N/A
N/A
Federated Hermes Equity Income F
WRAIX14.13N/A
N/A
Wilmington Global Alpha Equities I
AVUYX8.33N/A
N/A
American Century Value Y
WCMLX12.95N/A
N/A
WCM Small Cap Growth Institutional

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-3.42%
DNLI - ELVN
51%
Loosely correlated
-4.47%
SYRE - ELVN
50%
Loosely correlated
+1.08%
CRNX - ELVN
49%
Loosely correlated
+1.91%
ERAS - ELVN
48%
Loosely correlated
+1.75%
XNCR - ELVN
48%
Loosely correlated
N/A
More